BiTE The Dust: T Cell-Engaging Antibody Therapies to Eliminate Autoreactive Immune Compartments in Rheumatic Diseases

Moderator(s)

• 

  Roberto Caricchio, MD

  Professor of Medicine, Chief of the Division of Rheumatology
  University of Massachusetts Chan Medical School
  Worcester, Massachusetts, United States

  Disclosure(s): Cabaletta: Consultant (Terminated); GlaxoSmithKlein(GSK): Advisor or Review Panel Member (Ongoing); Neovii: Advisor or Review Panel Member (Ongoing); Novartis: Advisor or Review Panel Member (Ongoing)

Session Coordinator(s)

• AA

  Anca Askanase, MD, MPH

  Director
  Columbia University Medical Center
  New York, New York, United States

  Disclosure(s): Alumis: Advisor or Review Panel Member (Ongoing); Amgen: Advisor or Review Panel Member (Terminated, August 15, 2024); AstraZeneca: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bristol-Myers Squibb(BMS): Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Cabaletta: Grant/Research Support (Ongoing); Genentech: Grant/Research Support (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Idorsia: Grant/Research Support (Ongoing); Janssen: Advisor or Review Panel Member (Ongoing); NKARTA: Grant/Research Support (Ongoing); Novartis: Advisor or Review Panel Member (Ongoing); Sanofi: Grant/Research Support (Ongoing); UCB: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing)

Presentations:

• 8:30 AM – 9:00 AM Central Time

  T-Cell Engagers in Oncologic Indication
  

  Speaker: Lorenzo Falchi, MD – Memorial Sloan Kettering Cancer Center
• 9:00 AM – 9:30 AM Central Time

  Allogeneic CARs and T-Cell Engagers in SLE
  

  Speaker: Anca Askanase, MD, MPH – Columbia University Medical Center